Peter Palese

Peter Palese is a United States microbiologist, researcher, inventor and the Horace W. Goldsmith Professor in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City, and an expert in the field of RNA viruses.

Palese is the author of multiple book chapters and more than 500 scientific publications. He is also on the editorial board for Proceedings of the National Academy of Sciences of the United States of America (PNAS). He has been awarded multiple patents on viral vaccines and antivirals. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'Peter Palese', query time: 0.02s Refine Results
  1. 1
    A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates.

    A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. by Florian Krammer, Irina Margine, Gene S Tan, Natalie Pica, Jens C Krause, Peter Palese

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models

    Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models by Irene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, Marta Boza, Stephen McCroskery, Nicholas Lemus, Stefan Slamanig, Stefan Slamanig, Gagandeep Singh, Gagandeep Singh, Prajakta Warang, Prajakta Warang, Temima Yellin, Anass Abbad, Juan Manuel Carreño, Victoria Dolange, Jose Luis Martínez-Guevara, Gagandeep Singh, Marina Barcena-Varela, Lauren A. Chang, Lauren A. Chang, Michael Schotsaert, Michael Schotsaert, Michael Schotsaert, Michael Schotsaert, Florian Krammer, Florian Krammer, Florian Krammer, Florian Krammer, Peter Palese, Peter Palese, Weina Sun

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version

    Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75... by Gregorio Carballo-Uicab, Gregorio Carballo-Uicab, Gregorio Carballo-Uicab, Gabriela Mellado-Sánchez, Gabriela Mellado-Sánchez, Edith González-González, Edith González-González, Juana Salinas-Trujano, Juana Salinas-Trujano, Ivette Mendoza-Salazar, Ivette Mendoza-Salazar, Ivette Mendoza-Salazar, Karina López-Olvera, Karina López-Olvera, Keyla M. Gómez-Castellano, Keyla M. Gómez-Castellano, Ma. Isabel Salazar, Jesús M. Torres-Flores, Héctor Elías Chagoya-Cortés, Georgina Paz-De la Rosa, Ignacio Mena, Oscar Rojas-Martínez, Jesús Horacio Lara-Puente, Gustavo Javier Peralta-Sánchez, David Sarfati-Mizrahi, Alejandro Torres-Flores, Alejandro Torres-Flores, Weina Sun, Florian Krammer, Florian Krammer, Florian Krammer, Florian Krammer, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Peter Palese, Constantino López-Macías, Bernardo Lozano-Dubernard, Sonia M. Pérez-Tapia, Sonia M. Pérez-Tapia, Sonia M. Pérez-Tapia, Juan C. Almagro, Juan C. Almagro, Juan C. Almagro

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: